Clinical Trial: A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer

Sponsor and Collaborators
Roswell Park Cancer Institute

Contact
Contact: Roswell Park Cancer Institute
1-877-ASK-RPCI
AskRPCI@roswellpark.org


Continue Reading

Principal Investigator
Roberto Pili, MD Roswell Park Cancer Institute

ClinicalTrials.gov Identifier

NCT01037257